News & Analysis on Clinical Trial Services & Contract Research And Development
BioWa has announced it is to commence Phase 1 clinical trials anti-IL-5 receptor monoclonal antibody (Mab), which is being developed for the treatment of asthma, a respiratory disorder that is on the rise, particularly in children.
Scientists have mapped the entire genetic sequence of breast and colon cancers, which could lead to better ways to diagnose cancer in its early, most treatable stages, as well as further develop personalised treatments.
China offers Western firms a huge opportunity, but those operating in the country should be very mindful of introducing key technologies.
A start-up company has given new hope for patients with brain tumour by developing a new medical device that it claims is the first ultrasound-based system to allow drug delivery to the brain.
A white paper that looks at the eClinical business model strategies has concluded that larger investments and access to multicomponent, single-source contracting options will create more efficient models for businesses.
Qiagen, today announced that it has acquired all outstanding shares of Genaco Biomedical Products in a deal that adds PCR-based, multiplexed molecular diagnostics technologies and panels to Qiagen's portfolio.
UK-based Synexus Clinical Research is continuing its global movements with the latest acquisition of South African outfit Clinical Research Centers (CRC).
Patients can more easily swallow film-coated oval shaped tablets than any other commonly manufactured solid drugs, according to a new study.